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In eukaryotes and Archaea, selenocysteine synthase (SecS)
converts O-phospho-L-seryl-tRNA[Ser]Sec into selenocysteyltRNA[Ser]Sec using selenophosphate as the selenium donor compound. The molecular mechanisms underlying SecS activity are
presently unknown. We have delineated a 450-residue core of
mouse SecS, which retained full selenocysteyl-tRNA[Ser]Sec synthesis activity, and determined its crystal structure at 1.65 Å resolution. SecS exhibits three domains that place it in the fold type
I family of pyridoxal phosphate (PLP)-dependent enzymes. Two
SecS monomers interact intimately and together build up two
identical active sites around PLP in a Schiff-base linkage with
lysine 284. Two SecS dimers further associate to form a
homotetramer. The N terminus, which mediates tetramer formation, and a large insertion that remodels the active site set
SecS aside from other members of the family. The active site
insertion contributes to PLP binding and positions a glutamate
next to the PLP, where it could repel substrates with a free ␣-carboxyl group, suggesting why SecS does not act on free O-phospho-L-serine. Upon soaking crystals in phosphate buffer, a previously disordered loop within the active site insertion
contracted to form a phosphate binding site. Residues that are
strictly conserved in SecS orthologs but variant in related
enzymes coordinate the phosphate and upon mutation corrupt
SecS activity. Modeling suggested that the phosphate loop
accommodates the ␥-phosphate moiety of O-phospho-L-seryltRNA[Ser]Sec and, after phosphate elimination, binds selenophosphate to initiate attack on the proposed aminoacrylyltRNA[Ser]Sec intermediate. Based on these results and on the
activity profiles of mechanism-based inhibitors, we offer a
detailed reaction mechanism for the enzyme.
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Organisms that co-translationally incorporate selenocysteine (Sec)2 into proteins in response to UGA codons in mRNA
are frequently encountered in all three domains of life, prokaryotes, Archaea, and eukaryotes. The human genome contains 25 known genes encoding selenoproteins (1), several of
which have essential functions. Selenoprotein biosynthesis
requires two specialized metabolic pathways, the first to synthesize Sec and the second to incorporate Sec into proteins. The
benefits of selenoproteins, e.g. their unique redox and catalytic
properties, apparently outweigh selenium toxicity and the burden of maintaining intricate Sec synthetic and decoding
machineries.
Notwithstanding some common themes, both Sec synthesis
and decoding (for reviews, see Refs. 2– 4) differ in bacteria and
eukaryotes, and archaeal selenoprotein biosynthesis largely follows the eukaryotic schemes (5). In all organisms a special
tRNA[Ser]Sec bearing an anticodon complementary to the UGA
codon is central to both processes (6, 7). All tRNA[Ser]Sec species
exhibit a number of non-canonical features whereby they are
exclusively utilized for the Sec synthesis and Sec insertion pathways (8).
For Sec insertion at UGA codons, selenocysteyl-tRNA[Ser]Sec is
recognized by a special elongation factor, SelB in bacteria (9)
and EFSec in eukaryotes (10, 11), that replaces EF-Tu and
EF-1␣ in escorting the aminoacylated Sec-tRNA[Ser]Sec to the
ribosome. Bacterial SelB binds a stem-loop structure located
within the coding region of selenoprotein mRNAs and directly
downstream of a UGA codon (12). Such stem-loop structures
thereby act as Sec insertion sequence elements that recode
UGA, which normally signals translational termination. In contrast to bacteria, eukaryotic Sec insertion sequence elements
are located in the 3⬘-untranslated regions of selenoprotein
mRNAs (13), alleviating the burden of having to maintain functional secondary structures within the coding region and facilitating insertion of more than one Sec into a single protein
chain. Such recognition from a distance requires a special adaptor protein, Sec insertion sequence-binding protein 2 (14).
Additional factors appear to be involved in UGA recoding in
2

The abbreviations used are: Sec, selenocysteine; SecS, selenocysteine synthase; PSer, O-phospho-L-serine; PSerCysS, O-phospho-L-serine-cysteine
synthase; afu, A. fulgidus; F3-Ala, trifluoroalanine; mmu, M. musculus; PG,
propargylglycine; PLP, pyridoxal phosphate; SeP, selenophosphate; syn,
Synechocystis; Trx, thioredoxin; SLA/LP, soluble liver antigen/liver and pancreas antigen; P-loop, phosphate loop.
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higher organisms. For example, SECp43 was recently found to
associate with a Sec-tRNA[Ser]Sec䡠EFsec complex in vitro and to
enhance the interaction between EFsec and Sec insertion
sequence-binding protein 2 in vivo (15). SECp43 also influences
the specific post-transcriptional modification of tRNA[Ser]Sec
(16). Furthermore, a role for ribosomal protein L30 in Sec
decoding on the ribosome has recently surfaced (17).
Sec synthesis invariably takes place on tRNA[Ser]Sec (6, 7, 18),
which is initially aminoacylated with serine by seryl-tRNASer
synthetase (6, 19). The pathways then diverge in the different
domains and recapitulate a trend seen with the decoding systems; i.e. eukaryotes rely on a more complex ensemble of factors. In bacteria, a pyridoxal phosphate (PLP)-dependent
enzyme, selenocysteine synthase (SelA), uses selenophosphate
(SeP) to directly convert Ser-tRNA[Ser]Sec into Sec-tRNA[Ser]Sec
(20). However, in eukaryotes Ser-tRNA[Ser]Sec is first phosphorylated by O-phospho-L-seryl (PSer)-tRNA[Ser]Sec kinase to
produce PSer-tRNA[Ser]Sec (21). Phosphate apparently is
required as a leaving group by eukaryotic Sec synthase (SecS),
which subsequently gives rise to Sec-tRNA[Ser]Sec. In bacteria
SeP is provided by selenophosphate synthetase, SelD (22).
Eukaryotes harbor two homologs of SelD, selenophosphate
synthetases 1 and 2 (23), but only selenophosphate synthetase 2
can synthesize SeP for Sec synthesis (24).
The molecular identity of eukaryotic/archaeal SecS has only
recently been elucidated. An archaeal open reading frame,
annotated as SecS, did not act on Ser-tRNA[Ser]Sec or PSertRNA[Ser]Sec (25). RNA-mediated interference technology provided the first direct evidence for an essential role of soluble
liver antigen/liver and pancreas antigen (SLA/LP) in selenoprotein biosynthesis (16). SLA/LP was originally identified as the
target of autoantibodies from patients with a severe form of
autoimmune chronic active hepatitis (26, 27). Indeed, SLA/LP
interacted with SECp43 and tRNA[Ser]Sec as detected by coimmunoprecipitation (16, 26, 28). Structural homology modeling predicted that SLA/LP is a PLP-dependent enzyme of the
aspartate aminotransferase family (29). Unequivocal evidence
that SLA/LP embodied the elusive eukaryotic/archaeal SecS
was finally provided independently by two groups (28, 30) who
directly demonstrated the conversion of PSer-tRNA[Ser]Sec to
Sec-tRNA[Ser]Sec by the enzyme.
The identification of eukaryotic/archaeal SecS paved the way
for understanding the molecular mechanisms underlying its
catalytic activity. Xu et al. (28) showed that mouse SecS is able
to dephosphorylate PSer-tRNA[Ser]Sec, indicating that aminoacrylyl-tRNA[Ser]Sec is a likely intermediate in the reaction. It
was also unequivocally established that SecS employs SeP produced by selenophosphate synthetase 2 as the activated selenium donor (24, 28). Apart from these aspects, the enzyme is
presently enigmatic. In particular, it is not known (i) how SecS
recognizes its two substrates (PSer-tRNA[Ser]Sec and SeP) and
whether binding occurs concomitantly or sequentially, (ii) how
SecS differs from related enzymes that recognize low molecular
weight amino acid substrates, (iii) whether and how the enzyme
discriminates against free PSer, and (iv) which residues participate in PSer to Sec conversion on tRNA[Ser]Sec.
Here we report on a combined structural and biochemical
analysis of a mammalian SecS which illuminates the above
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questions. We determined high resolution crystal structures of
SecS from mouse (mmuSecS) in which we find that the active
site is constructed around a Lys-284-bound PLP cofactor at the
interface of two protomers of a close dimer. A SecS-specific N
terminus leads to association of two dimers into a homotetramer, which has possible relevance for PSer-tRNA[Ser]Sec positioning. The active site is complemented by a SecS-specific
loop, which is disordered in the absence of ligands but contracts
in the presence of a substrate-mimicking phosphate moiety. A
glutamate neighboring the PLP cofactor is ideally positioned to
deter substrates bearing a free ␣-carboxyl group. In line with
the structural results, we show that changes of phosphate-coordinating residues, which are solely conserved in SecS
orthologs, lead to reduced activity of the enzyme and that
SecS does not act on free PSer. Using in addition the
response of SecS toward mechanism-based inhibitors, we
propose a detailed catalytic mechanism.

EXPERIMENTAL PROCEDURES
Protein Production and Site-directed Mutagenesis—A DNA
fragment encoding the full-length secS gene from mouse (GenBankTM accession number NM_172490) was amplified and
cloned into pETM-13 vector to allow the expression of a C-terminal His6-tagged protein. The insert was verified by DNA
sequencing. The resulting plasmid was termed pETM-13-secS.
Rosetta2(DE3) cells were transformed with the pETM-13secS expression construct. Overproduction of the target protein
was carried out at 289 K using auto-inducing medium (31).
Cells were harvested when the maximum culture density was
reached and resuspended in buffer A (50 mM HEPES-NaOH,
pH 7.5, 500 mM NaCl, 20 mM imidazole, 2 mM ␤-mercaptoethanol). 1 mg of lysozyme and 3 l of DNase (1 mg/ml) were
added per gram of wet cells, and the mixture was incubated for
30 min on ice with stirring. After completing cell rupture by
sonication and removing cell debris by centrifugation, soluble
fusion protein was captured on a nickel-nitrilotriacetic acidSepharose column (Qiagen), washed with buffer B (50 mM
HEPES-NaOH, pH 7.5, 1 M NaCl, 20 mM imidazole, 2 mM
␤-mercaptoethanol), and eluted with a linear gradient of imidazole (20 to 250 mM) in buffer A. Fractions containing
mmuSecS were pooled, concentrated, and further purified by
gel filtration on a Superdex-200 HiLoad 26/60 column (GE
Healthcare) equilibrated with buffer C (10 mM HEPES-NaOH,
pH 7.5, 500 mM NaCl, 2 mM dithiothreitol). Purified target protein was concentrated to 14 mg/ml using Vivaspin 15 concentrators (30,000 MWCO; Sartorius Vivascience), separated into
aliquots, flash-frozen in liquid nitrogen, and stored at 193 K
until use. Using the above protocol we obtained ⬃1.5 mg of
mmuSecS per liter of bacterial culture at a purity of greater than
95% as estimated by SDS-PAGE analysis (see Fig. 1A).
Mutants of mmuSecSArg-313 and mmuSecSGln-105 were generated in pETM-13-secS via the QuikChange protocol (Stratagene). The mutations were verified by DNA sequencing. All
mutants of mmuSecS were purified in the same way as the wild
type protein.
Limited Proteolysis and Analytical Gel Filtration Analysis—
50 l of mmuSecS (14 mg/ml) were incubated with 3 g of
elastase at 277 K for 80 min. The major band on an SDS gel
VOLUME 283 • NUMBER 9 • FEBRUARY 29, 2008
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originating from elastase treatment (mmuSecSelast; see Fig. 1A)
was in-gel-digested with trypsin, and fragments were analyzed
by matrix-assisted laser desorption ionization-mass spectroscopy as described (32).
Analytical gel filtration was conducted on a Superdex-200 PC
3.2/30 size exclusion column (2.4-ml gel bed, column dimensions 3.2 ⫻ 300 mm) on a SMART fast protein liquid chromatography system (GE Healthcare). Escherichia coli SelA (a
decamer of ⬃506 kDa), Saccharomyces cerevisiae cystathionine
␥-lyase (a tetramer of ⬃170 kDa), and Methanocaldococcus
jannaschii SelA-like protein (MJ0158; a dimer of ⬃84 kDa)
served as size standards.
In Vitro Transcription and Filter Binding Assay—The template for in vitro transcription was prepared as described (21).
Uniformly 32P-labeled tRNA[Ser]Sec was transcribed in 50 l of
transcription buffer (30 mM HEPES-NaOH, pH 8.0, 6.4 mM
MgCl2, 2 mM spermidine, 40 mM dithiothreitol, 400 M each of
GTP, CTP, and ATP, 200 M UTP, 40 Ci of [␣-32P]UTP (3000
Ci/mmol), 32 units of RNasin) containing 5 g of linearized
DNA template and 1.5 l of T7 RNA polymerase. The transcription mixture was incubated for 2 h at 310 K, and synthetic
tRNA[Ser]Sec was gel-purified.
10,000 cpm (100 fmol) of 32P-labeled unacylated tRNA[Ser]Sec
were incubated 30 min on ice with 2.5, 5, 10, or 20 M mmuSecS
or mmuSecSelast in 20 l of buffer D (HEPES-NaOH, pH 7.5,
200 mM NaCl, 5 mM MgCl2, 1 mM dithiothreitol, 0.5 mg/ml
total E. coli tRNA). 10-l aliquots of the reaction mixtures were
loaded on a Protran BA 83 nitrocellulose membrane (Whatman) and washed with 50 ml of buffer C. For the detection of
RNA-protein complexes, the membrane was exposed to a
PhosphorImager screen overnight, which was then scanned
using a Typhoon 8600 (GE Healthcare).
SecS Activity Assay—Synthetic tRNA[Ser]Sec was used in all
reactions for assaying SecS activity. Synthetic tRNA[Ser]Sec was
aminoacylated with serine by seryl-tRNASer synthetase, the seryl
moiety was phosphorylated (21), and the PSer-tRNA[Ser]Sec was
isolated (28). The extent of serylation of tRNA[Ser]Sec in the
presence of seryl-tRNASer synthetase, serine, and other reaction components was 80 –90%, and subsequent phosphorylation in the presence of PSer-tRNA[Ser]Sec kinase, ATP, and
other reaction components neared 100% (Refs. 21 and 28 and
references therein).3 The preparations of seryl-tRNASer synthetase and PSer-tRNA[Ser]Sec were exactly as described elsewhere
(see Ref. 21 and references therein). Because less than 20%
spontaneous deacylation of the aminoacyl-tRNA[Ser]Sec constituents occurs during their preparation and use (Ref. 21 and
references therein), the relative amounts of tRNA[Ser]Sec, seryltRNA[Ser]Sec, and PSer-tRNA[Ser]Sec used in reactions with SecS
generating Sec-tRNA[Ser]Sec can be estimated to be ⬃45:0:55,
respectively, wherein an ⬃20% deacylation occurs at both steps
involving PSer-tRNA[Ser]Sec preparation.
The activities of mmuSecSelast and of the mmuSecS point
mutants relative to that of the full-length wild type mmuSecS
were determined. Thioredoxin (Trx) was used as a negative
control. Sec synthetic reactions were carried out as described

3

X.-M. Xu, B. A. Carlson and D. L. Hatfield, unpublished data.
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(28). The selenium donor, SeP, was generated from chemically
synthesized [(CH3)3SiO]3PSe (28), which was a generous gift of
Dr. Richard Glass, and 0.2 mM SeP was used in all Sec synthesis
assays.
Dephosphorylation Activity of mmuSecS—Dephosphorylation of PSer-tRNA[Ser]Sec was carried out as described (28) with
the following modifications. In the inhibition assays, mmuSecS
was incubated with different concentrations of propargylglycine (PG) or trifluoroalanine (F3-Ala) for 3 min at room temperature in a 10-l volume of buffer (28), 100 ng of 32P-labeled
and 1.0 g of cold PSer-tRNA[Ser]Sec were added to bring the
total volume to 20 l, and the reaction was incubated at 310 K
for 15 min. To assess the activity of mmuSecS on free PSer, a
stock solution of [32P]PSer was prepared by deacylating 0.5 g
of [32P]PSer-tRNA[Ser]Sec in 25 l at pH 9.0 and 315 K for 1 h. 5
l of [32P]PSer were added to each of the mmuSecS reactions
and then incubated for 15 min at 310 K. 10 units of alkaline
phosphatase were used to dephosphorylate [32P]PSer, and the
resulting phosphate was used as a positive control. Reactions
were prepared for chromatography and chromatographed as
given (28).
Crystallographic Procedures—For crystallization, 1.5 l of
mmuSecSelast (14 mg/ml in buffer C) were mixed with an equal
volume of reservoir solution (11% [v/v] ethylene glycol without
other buffer components) in a 24-well Cryschem plate (Hampton Research) immediately after elastase treatment. Crystals
were grown by sitting-drop vapor diffusion at 293 K. They
appeared overnight and continued to grow for the next 2 days.
For data collection, crystals of mmuSecSelast were shock-frozen
in a 100 K nitrogen stream (Oxford Cryosystems) after transfer
into a cryo-protecting buffer (100 mM HEPES-NaOH, pH 7.5,
250 mM NaCl, 1 mM dithiothreitol, 35% (v/v) ethylene glycol).
All data were recorded on a Bruker-Nonius FR591 rotating
anode generator producing CuK␣ X-radiation ( ⫽ 1.54179 Å)
at 45 kV and 100 mA equipped with Osmic mirrors and a
MAR345 image plate (MARResearch). Data were processed
with the HKL package (33) (Table 1).
The structure of mmuSecSelast was solved via a single isomorphous replacement with anomalous scattering strategy.
Crystals were soaked for 30 s in cryo-protecting buffer supplemented with 0.5 M sodium iodide and immediately shockfrozen in a 100 K nitrogen stream. Friedel pairs were kept separate during data reduction (Table 1). The iodide-soaked
crystals proved isomorphous to the native crystals. 42 iodide
positions were found by using SHELXD (34) and used for initial
phase calculations (Table 1). Solvent flattening with SHELXE
clearly indicated the correct hand of the heavy atom substructure (Table 1) and yielded a high quality experimental electron
density map (supplemental Fig. S1).
424 of the 438 residues located in the final structure were
positioned in the first round of automatic model building with
ARP/wARP (35). The structure was completed by manual
model building and automatic refinement with Refmac5 (36).
Water molecules were automatically placed with ARP/wARP.
One solute species was identified as a chloride ion based on the
presence of 250 mM NaCl in the crystallization buffer and residual positive electron density after placement of a water molecule. Another solvent molecule was interpreted as an ethylene
JOURNAL OF BIOLOGICAL CHEMISTRY
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glycol molecule originating from the crystallization or cryoprotecting buffer. TLS refinement (37) was conducted to model
differential global anisotropic displacements of the three
domains of mmuSecSelast. During all stages of refinement, a
randomly selected set of 5% of the reflections was used for
cross-validation (Table 1). The iodide-soaked crystal structure
was refined by the same strategy including the 42 iodide ions
located by SHELXD. Additional, lower occupancy iodide positions were found in an anomalous difference Fourier map,
obtained with phases calculated from the final refined native
structure and the anomalous differences measured for the
iodide data set.
For monitoring of phosphate binding, crystals were soaked
for 1 min in cryo-protecting buffer supplemented with 0.5 M
sodium phosphate, pH 7.5. Similarly, crystals could be derivatized with sulfate (not shown). Data were collected as described,
and the structure of a phosphate-soaked crystal was solved by
molecular replacement with MOLREP (38) using the structure
coordinates of the native protein as a search model while omitting the solvent structure, the PLP cofactor, and alternative side
chain conformations. Model building and refinement were
conducted as described for the native protein (Table 1). Coordinates and structure factors have been submitted to the Protein Data Bank.

RESULTS
Limited Proteolysis Delineates a SecS Core Fully Active in
PSer-tRNA[Ser]Sec to Sec-tRNA[Ser]Sec Conversion—We
expressed, purified, and crystallized full-length SecS from
mouse (mmuSecS), but the crystals diffracted only to ⬃6 Å
resolution. To explore the possibility that flexible regions hindered generation of well ordered crystals, mmuSecS (⬃55 kDa)
was digested with various proteases. Elastase gave rise to a stable fragment of about 49 kDa (Fig. 1A). Tryptic mass spectrometric fingerprinting showed that the elastase-resistant fragment encompassed residues 19 – 468 (not shown). Thus, the
protease removed most of the C-terminal portion that carries
the main SLA/LP antigenic epitope (26, 27), also lacking in
archaeal SecS (Fig. 2). We refer to the elastase-resistant core of
the enzyme as mmuSecSelast.
Gel filtration analysis revealed that mmuSecS is tetrameric in
solution (Fig. 1B). Elastase treatment did not change the migration behavior of the protein detectably, showing that the proteolytic treatment left the quaternary structure of the enzyme
intact (Fig. 1B). Because mmuSecS binds significantly to unacylated tRNA[Ser]Sec (28), we examined the tRNA[Ser]Sec binding
activity of mmuSecSelast by nitrocellulose filter binding. The
elastase-treated protein bound tRNA[Ser]Sec with an affinity and
specificity comparable with those of the full-length enzyme
(Fig. 1C). We next tested the Sec synthesis activity of mmuSecSelast using a paper chromatographic assay (28). After removal
of elastase by gel filtration chromatography, mmuSecSelast was
incubated with buffer containing SeP and PSer-tRNA[Ser]Sec
(obtained by phosphorylation of Ser-tRNA[Ser]Sec by PSertRNA[Ser]Sec) (21, 28). As positive and negative controls,
mmuSecS and Trx, respectively, were substituted for mmuSecSelast. The efficiency at which mmuSecSelast converted PSertRNA[Ser]Sec to Sec-tRNA[Ser]Sec was indistinguishable from
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FIGURE 1. Characterization of mmuSecSelast. A, SDS-PAGE of mmuSecS (lane
1) and mmuSecSelast (lane 2). M, molecular weight markers. B, analytical gel
filtration analysis of mmuSecS (red) and mmuSecSelast (gold), E. coli SelA
(ecoSelA) (black, ⬃506 kDa), S. cerevisiae cystathionine ␥-lyase (sceCGL; blue,
⬃170 kDa), and MJ0158 (green, ⬃84 kDa) served as molecular mass markers.
Peaks containing the respective proteins (arrows) were verified by monitoring the absorbance at 420 nm and by SDS-PAGE analysis (not shown). The
high molecular weight peak (left) in the full-length mmuSecS run represents a
contaminating nucleic acid fraction. C, filter binding assay showing similar
affinity of mmuSecS (top panel) and mmuSecSelast (bottom panel) for deacylated tRNA[Ser]Sec. Experiments were conducted in the presence of unlabeled
competitor tRNA and, thus, represent specific affinities. Concentrations of
protein in the reactions are indicated. D, conversion of [3H]PSer-tRNA[Ser]Sec to
[3H]Sec-tRNA[Ser]Sec by mmuSecS (red) and mmuSecSelast (gold and blue, which
are duplicates, mmuSecSelast 1 and mmuSecSelast 2). Trx (black) served as a
negative control. Details are given under “Experimental Procedures.”

that of the full-length enzyme (Fig. 1D). The above results demonstrate that mmuSecSelast structurally and functionally closely
resembles the full-length enzyme and constitutes a suitable
platform on which to explore the structure-activity relationships of SecS-dependent Sec biosynthesis.
SecS Is a Member of the Fold Type I Family of PLP-dependent
Enzymes with Distinct Structural Elements—mmuSecSelast crystallized readily after the addition of 11% (v/v) ethylene glycol at
room temperature. The crystals diffracted to high resolution on a
rotating anode x-ray generator and could be derivatized by quicksoaking in 0.5 M sodium iodide for structure solution by single
isomorphous replacement with anomalous scattering (Table 1;
Fig. S1). Refinement converged at R/Rfree factors of 16.8/19.8%
with the final model exhibiting good overall stereochemistry
(Table 1). The only amino acids lacking well defined electron density were residues 19 –22 at the N terminus, residue 468 at the C
terminus, and residues 98 –104, constituting a flexible loop.
VOLUME 283 • NUMBER 9 • FEBRUARY 29, 2008
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Structural homology searches (39) suggested that mmuSecSelast exhibits significant similarity to the fold type I family of
PLP-dependent enzymes (also referred to as the aspartate aminotransferase family) (40). Where appropriate, we will compare
the structure of mmuSecSelast to those of Archaeoglobus fulgidus PSer-cysteine synthase (afuPSerCysS) (41), members of
the NifS family of Cys/Sec lyases (42– 46), and the cystine
C-S lyase C-DES from Synechocystis (synC-DES) (47). A
quantitative comparison with these proteins is given in
Table 2. These enzymes act or can act on related substrates
and may share some catalytic properties with SecS. In particular, PSerCysS from methanogenic Archaea affords a precedence for the tRNA-based amino acid synthesis via a PSertRNA intermediate. In these organisms the sole pathway for
cysteine biosynthesis is via PSer-tRNACys, obtained by direct
aminoacylation of tRNACys with PSer by PSer-tRNACys synthetase, and subsequent PSer-tRNACys to Cys-tRNACys conversion by PSerCysS (48).
mmuSecSelast can be divided into three domains (Fig. 3, A
and B). Domain 1 (blue scaffold in Fig. 3, A and B) is a composite
of residues 23–130 and 313–330 and is purely ␣-helical
(encompassing helices ␣1-␣4 and ␣12). The N terminus (residues 23– 44; element I in Fig. 3, A and B) differs from that of
other fold type I enzymes (Fig. 3, C and D). In mmuSecSelast,
helix ␣1 is positioned at the protein surface, running approximately perpendicular to the scaffolding helices of the domain.
Domain 1 also exhibits a long insertion between helices ␣2 and
␣4 (residues 62–108; element II in Fig. 3, A and B), which
encompasses two loops separated by helix ␣3. The corresponding element in other enzymes of the fold type I family is significantly shorter (Fig. 3, C and D). Seven residues within the second loop of the insertion (residues 98 –104) are disordered due
to intrinsic flexibility (bordered by spheres in Fig. 3A). Both the
non-canonical N terminus and the unique insertion are conserved among SecS orthologs (Fig. 2) and, therefore, are
expected to confer unique functions on the enzyme.
Domain 2 of SecS is the largest module of the protein
(residues 131–312; cyan scaffold in Fig. 3, A and B). It comprises a ␣/␤/␣ sandwich fold encompassing a sevenstranded ␤-sheet (␤1-␤9-␤8-␤7-␤6-␤2-␤3) characteristic of
the fold type I family. The ␤-sheet is parallel except for
strand ␤9 (Fig. 3, A and B). A short helix (␣10) between
strands ␤8 and ␤9 carries a PLP cofactor in Schiff-base linkage to Lys-284 (Figs. 3A and 4). Helices ␣7, ␣8, and ␣9 line
the ␤-sheet at the convex outside, and helices ␣5, ␣6, and
␣11 lie at the concave inside. A short ␤-hairpin (␤4 and ␤5)
is inserted between strand ␤3 and helix ␣7. Domain 2 is
connected to the second part of domain 1 by a short loop
(residues 311–314; element III in Fig. 3, A and B).
Domain 3 of SecS (residues 331– 467; steel blue scaffold in
Fig. 3, A and B) exhibits an ␣/␤ sandwich fold with three almost
parallel helices (␣13, ␣14, and ␣15) on the outside covering an
antiparallel three-stranded ␤-sheet (␤10-␤14-␤11), which in
turn rests on top of domain 2. A long loop (residues 408 – 430;
element IV in Fig. 3, A and B) with a ␤-hairpin (␤12-␤13) at the
tip is inserted between strands ␤11 and ␤14. The threestranded ␤-sheet and the ␤-hairpin of the loop are at approximately right angles and encircle part of domain 2 (Fig. 3A).
FEBRUARY 29, 2008 • VOLUME 283 • NUMBER 9

Strands ␤11 and ␤12 thereby form one rim of an active site
funnel leading from the surface to the PLP (Fig. 3A). In the
NifS-like enzymes, the analog of the long domain 3 loop (element IV) is often disordered (43) and bears a conserved Cys that
can be charged in the active site with elemental sulfur. The
resulting persulfide is thought to donate a S0 building block for
iron-sulfur cluster biosynthesis. Element IV of mmuSecSelast
does not contain a Cys.
Cross-strutting via the N Nerminus Leads to Homotetramers
That Exhibit Surface Properties Suitable for Binding
PSer-tRNA[Ser]Sec—mmuSecSelast crystals contained one protein molecule per asymmetric unit. Consistent with the gel filtration analysis, the orthorhombic crystal symmetry gave rise to
tetramers in which the protomers are related by three orthogonal 2-fold axes (see Fig. 5A, left). Within a tetramer, two pairs
of monomers (Mol I/II and Mol III/IV; Fig. 5A, left) interact
intimately, burying 7343 Å2 of combined surface area upon
association. Two of these close dimers further associate into
tetramers via less extensive interactions between Mol I and Mol
III, viz. Mol II/Mol IV (1891 Å2 combined surface area buried in
each contact), and between Mol I and Mol IV, viz. Mol II/III
(276 Å2 combined surface area buried in each contact; Fig. 5A,
left). The tetramers are held together by the formation of a short
antiparallel coiled-coil between the ␣2 helices of Mol I and III
(Mol II and IV), which is cross-strutted by helices ␣1 (Fig. 5B).
In contrast, afuPSerCysS, NifS relatives, or synC-DES lack the
surface-exposed N terminus (elements I in Fig. 3, C and D).
Consistently, all these latter proteins exist as dimers.
Fig. 5C shows the electrostatic potential mapped to the surface of a mmuSecSelast tetramer. Large patches of positive
charge (blue) are visible, consistent with the overall basic pI of
8.3 calculated for the protein. In particular, the funnel leading
to the active site is strongly positively charged. Therefore, the
surface properties of mmuSecSelast appear to be designed to
contact the sugar-phosphate backbone of tRNA[Ser]Sec at multiple positions. Consistent with this view, we observed avid
binding of anions to mmuSecSelast. After soaking with NaI, we
located 62 iodide ions per protomer bound to the surface of
mmuSecSelast (Fig. 5D). One of these positions was always occupied by a chloride ion in structures not treated with iodide (not
shown).
The PLP Cofactor Is Tightly Anchored by Non-canonical Contacts to Both Protomers of a Close Dimer—A close dimer exhibits two identical active sites at the protomer interfaces pinpointed by a PLP cofactor (Fig. 4A). Because the PLP was
refined at full occupancy, leaving no residual difference density,
all four subunits of a tetramer bear a cofactor. This situation is
different from afuPSerCysS, where only one of two potential
active sites in a dimer was equipped with PLP (41). We refer to
the PLP attached to Lys-284 of a reference molecule and the
surrounding active site as “cis”; the PLP attached to the opposite protomer and its surrounding active site are referred to as
“trans.”
In mmuSecSelast, both monomers of a close dimer contribute side chains for PLP binding in an active site (Fig. 4A).
Apart from the covalent linkage to Lys-284, PLP is additionally bound via multiple hydrogen bonds and electrostatic
and van der Waals interactions in cis. These interactions
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TABLE 1
Crystallographic data
r.m.s.d., root mean square deviation; ESU, estimated overall coordinate error based on maximum likelihood.
Data collection
Space group
Unit cell parameters (a, b, c; Å)
Resolution (Å)
Reflections
Unique
Completeness (%)
Redundancy
I/(I)
Rsym(I)b
Phasing
Resolution (Å)
Heavy atom sites
Correlation coefficientsc
SHELXD CCall/CCweak
SHELXE CCoverall
CCfree left/right hand
FOMd
Refinement
Resolution (Å)
Reflections
Number
Completeness (%)
Test set (%)
Rworke
Rfreee
ESU (Å)
Contents of asymmetric unit
Protein molecules/residues/atoms
Water oxygens
PO43⫺/Cl⫺/I⫺
Mean B-factors (Å2)
Wilson
Protein
Water
Ions
Ramachandran Plotf
Favored
Allowed
Outliers
r.m.s.d. target geometry
Bond lengths (Å)
Bond angles (°)
r.m.s.d. B-factors (Å2)
Main chain bonds
Main chain angles
Side chain bonds
Side chain angles

Native

Iodide

Phosphate

I222
59.2, 138.7, 141.7
30.0-1.65 (1.74-1.65)a

I222
59.2, 138.4, 141.5
50.0-2.25 (2.38-2.25)a

I222
59.2, 138.7, 141.7
50.0-1.85 (1.95-1.85)

68,502 (9,938)
97.3 (95.3)
4.7 (4.5)
20.5 (2.1)
0.045 (53.9)

52,394 (7,738)
98.3 (97.0)
4.7 (4.7)
13.4 (3.8)
0.093 (35.4)

49,649 (7,322)
99.3 (99.2)
3.5 (3.1)
16.3 (1.90)
0.046 (54.2)

20.0-1.65 (1.69-1.65)

30.0-2.25 (2.31-2.25)

20.0-1.85 (1.99-1.85)

65,002 (4,662)
97.3 (95.0)
5.1
0.168 (0.390)
0.198 (0.401)
0.061

26,104 (1,839)
98.0 (96.3)
5.0
0.183 (0.199)
0.237 (0.303)
0.129

47,049 (3,157)
98.8 (93.0)
5.1
0.166 (0.341)
0.202 (0.372)
0.077

1/433/3647
723
⫺/1/⫺

–/–/–
264
⫺/⫺/50

1/441/–
509
2/1/⫺

20.0
15.1
38.4
16.5

32.2
26.9
28.7
45.9

23.9
21.0
38.2
45.9

97.9 (424/433)
1.9 (8/433)
0.2 (1/433)

97.7 (421/431)
2.1 (9/433)
0.2 (1/433)

97.7 (431/441)
2.3 (10/441)
0.0

0.012
1.34

0.010
1.22

0.010
1.19

0.726
1.122
2.005
3.152

0.423
0.787
1.402
2.318

0.563
0.894
1.604
2.540

30.0-2.0
42
50.86/37.73
35.52
62.69/26.92
0.582

a

Data for the highest resolution shell in parentheses.
Rsym(I) ⫽ ⌺hkl⌺i兩Ii(hkl) ⫺ 具I(hkl)典兩/⌺hkl⌺i兩Ii(hkl)兩 for n independent reflections and i observations of a given reflection; 具I(hkl)典, average intensity of the i observations.
c
CC ⫽ 关⌺wEoEc⌺w ⫺ ⌺wEo⌺cEc兴/{关⌺wEo2⌺w ⫺ (⌺wEo)2兴关⌺wEc2⌺w ⫺ (⌺wEc)2兴}½; w, weight (see SHELX software for full definitions).
d
Figure of merit (FOM) ⫽ 兩F(hkl)best兩/兩F(hkl)兩; F(hkl)best ⫽ SaP(␣)Fhkl(␣)/SaP(␣).
e
R ⫽ ⌺hkl ⫼ 兩Fobs兩 ⫺ 兩Fcalc兩 ⫼ /⌺hkl兩Fobs兩; Rwork, hkl ⰻ T; Rfree, hkl 僆 T; T, test set.
f
Calculated with MolProbity (58).
b

exclusively involve residues from domain 2. The PLP phosphate group is positioned over the N terminus of helix ␣5,
interacting favorably with the helix macro-dipole and engaging in hydrogen bonds to the backbone amides of Thr-144
and Gly-145. The pyridine nitrogen maintains hydrogen
bonds to the side chains of Cys-175 and Asn-252. Asn-252 is

at variance with the vast majority of fold type I enzymes, in
which an Asp at the equivalent position is the only strictly
conserved residue apart from the PLP-bound Lys (40). An
Asn is expected to support the electron sink character of the
pyridine ring less than an Asp, possibly demanding a good
leaving group such as a phosphate on the ␤-carbon. Interest-

FIGURE 2. Structure-based multiple sequence alignment of SecS and enzymes of the fold type I family. Structure-based multiple sequence alignment
generated by the 3DCoffee-option of TCoffee (57) and shaded by BoxShade. Sequences are numbered at the beginning of each line. The darker background
represents higher conservation. The background of the PLP lysines is in gold; the background of residues whose side chains contact PLP and of residues
contacting the P1 phosphate is in green. P-loop residues undergoing a disorder-order transition upon phosphate binding are boxed in red. Residues contacting
the P2 phosphate are indicated by a green arrowhead. Elements I–IV discussed in the text are indicated by labeled red bars above the alignment (see also Fig.
3). Active site loops 1 and 2 from element II are indicated by dashed lines below the alignment. Secondary structure elements as found in mmuSecSelast are
indicated below the alignment. Scaffolding elements are color-coded by domain; blue, domain 1; cyan, domain 2; steel blue, domain 3. Secondary structure
elements belonging to elements I–IV are in red, and helix ␣10 (bearing the PLP cofactor) is in gold. hsa, Homo sapiens; mmu, Mus musculus; dme,
Drosophila melanogaster; cel, Caenorhabditis elegans; mma, Methanococcus maripaludis; mja, M. jannaschii; afu, A. fulgidus; syn, Synechocystis; eco, E. coli;
tma, T. maritima.
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ingly, in afuPSerCysS, in which phosphate is also the leaving
group, the pyridine nitrogen is again bound to an Asn (Fig. 2)
(41). The PLP pyridine ring of mmuSecSelast is sandwiched
r.m.s.d., root mean square deviation.
between the side chains of Gln-172 and Ala-254 on the re
afuPSerCysS tmaNifS-like Protein synC-DES
and si faces, respectively. Archaeal SecS enzymes feature a
PDB code
2E7J
1EG5
1ELU
His in place of Gln-172 (Fig. 2). A similar His in a NifS-like
Reference
41
43
47
Sequence identity (%)
10.9
13.1
11.7
protein from Thermotoga maritima has been discussed as a
257
283
266
Matching C␣ atoms
a
tunable acid-base catalyst in the reaction mechanism (43).
2.8
2.8
3.0
r.m.s.d. (Å)
a
Thus, the enzymatic mechanisms of archaeal and eukaryotic
Structures were superimposed by secondary structure matching (59).
SecS may differ in detail.
Interactions with PLP in trans
(Fig. 4, A and B) involve residues
from the SecS-specific insertion in
domain 1 (element II) and from the
short element III connecting
domain 2 and the second part of
domain 1 (Fig. 3, A and B). Both elements primarily interact with the
PLP phosphate. Arg-75 (originating
from the first loop of element II) is
deposited on the phosphate side of
the PLP pyridine ring where its side
chain can engage in two charged
interactions with anionic phosphate
oxygens. Arg-75 is appropriately
positioned by a double salt bridge
interaction with Asp-283 from the
cis protomer (Fig. 4, A and B). The
preceding residue of element II,
Glu-74, comes to lie on the opposite
side of the pyridine ring and is
connected via water molecules to
the C3 hydroxyl group of PLP and
the nitrogen of the Schiff base. It is
kept in place by van der Waals
contacts to Tyr-255 of the cis protomer (Fig. 4, A and B). In addition, the backbone nitrogen of
Arg-313 (from element III) hydrogen bonds to an anionic phosphate
oxygen of the PLP.
In other fold type I PLP-dependent enzymes, element III is often
significantly longer than in SecS
(Fig. 3, C and D) and provides additional residues for binding the PLP
phosphate. In contrast, the region
corresponding to element II in
afuPSerCysS is much shorter than
in SecS (21 versus 47 residues) and is
completely disordered in the strucFIGURE 3. Domain organization and functional elements. A, orthogonal ribbon plots (front and bottom) of
mmuSecSelast. One protomer is in light gray, and the other protomer is color-coded according to domains (blue, ture (41), failing to provide stable
scaffold of domain 1; cyan, scaffold of domain 2; steel blue, scaffold of domain 3). Selected elements (I–IV) as PLP anchoring (Fig. 3C). In synCdiscussed in the text are shown in red and labeled with uppercase roman numerals for the reference molecule DES, the equivalents of helices
␣2
(Mol I) viz. in violet and labeled with lowercase roman numerals for the other protomer (Mol II). Helix ␣10,
bearing the PLP cofactor, is in gold. Selected ␣-helices are labeled as landmarks. B, secondary structure topol- and ␣4 are longer and place a very
ogy (large circles, ␣-helices; small circles, 310-helices; triangles, ␤-strands). The secondary structure elements are short element II, which is suslabeled, and their residue extents are indicated. They are colored as in A. C and D, ribbon diagrams of afuPSerCysS (C, PDB code 2E7J (41)) and synC-DES (D, PDB code 1ELU; (47)) dimers in the front view after global pended between them, remote from
superimposition of the proteins on mmuSecSelast. Coloring is the same as for mmuSecSelast.
the trans PLP and close to domain 3
TABLE 2
Structural comparison of three fold type I PLP-dependent enzymes
with mmuSecSelast
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FIGURE 4. PLP environment. A, stereo ribbon plot depicting the anchoring of PLP by two protomers of a close
dimer in native mmuSecSelast. The backbone of the molecule binding PLP in cis is shown in light gray, and the
backbone of the molecule binding in trans is in steel blue. The base of the disordered loop (P-loop; see also Fig.
6) is in green. The Lys-284-bound PLP and selected residues from both protomers are shown in ball-and-stick
representation and are color-coded by atom type (carbon, as the respective protein backbone; gold, carbon of
Lys-284-PLP; blue, nitrogen; red, oxygen; yellow, sulfur; pink, phosphorus). Red spheres designate water molecules. Dashed lines indicate hydrogen bonds and salt bridges. The view is rotated 30° about the vertical axis
compared with the front view in Fig. 3A. B, stereo ribbon plot of the remodeled neighborhood of PLP. Selected
residues are shown in ball-and-stick representations. Green, carbon of Arg-404. Other colors are as in A. Black
dashed lines indicate hydrogen bonds and salt bridges. The magenta dashed line shows a cation- stack of the
side chains of Arg-404 on Phe-227. The view is rotated 90° about the vertical axis compared with the front view
in Fig. 3A. C, stereo ribbon plot of the PLP neighborhood in a T. maritima NifS-like protein (PDB code 1EG5 (43))
after global superimposition on mmuSecSelast. The view and color-coding are the same as in panel B. Arg-350 of
T. maritima NifS is the equivalent of Arg-404 in mmuSecSelast. In the absence of a substrate it binds to a sulfate
ion mimicking a ␣-carboxylate.
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of the other protomer (Fig. 3D).
Thus, in other fold type I enzymes,
element II serves to reinforce
dimerization but does not contribute directly to the active sites.
Instead, in afuPSerCysS, NifS relatives and synC-DES a portion of the
N terminus is positioned between
domains 1 and 3 and harbors residues, which in some cases contact
the cis PLP (Fig. 3, C and D). In
mmuSecSelast, the first loop of the
long element II replaces this N-terminal part in trans (Fig. 3A).
In contrast to the situation within
a close dimer, there is no crosscommunication at the active sites
between molecules belonging to the
two different close dimers of a tetramer. This situation suggests that
the close dimers are sufficient to
provide the chemical microenvironment required for catalysis.
Binding of Phosphate Triggers
Disorder-Order Transition in an
Active Site Loop—Substrates of SecS
contain a number of phosphates or
phosphate-related groups, such as
the phosphodiester backbone of
tRNA[Ser]Sec, the ␥-phosphate of the
PSer moiety, and SeP. We reasoned
that phosphate could mimic binding of either of these groups at the
active site of SecS and determined
the crystal structure of mmuSecSelast after soaking crystals for 30 s in
0.5 M phosphate buffer. Strikingly,
we observed that a phosphate (P1 in
Fig. 6) is cradled in the second loop
of the domain 1 insertion (residues
98 –104 of element II; green in Fig.
6), which was previously disordered.
Upon phosphate binding, this loop
contracts and covers part of the
trans active site (Fig. 6, A and B).
Arg-313 originating from the loop
that connects domain 2 to the second part of domain 1 (element III in
Fig. 3, A and B) forms the base of the
P1 phosphate binding site. To bind
the P1 phosphate, Arg-313 and Gln105 (neighboring the previously disordered element) are profoundly
repositioned (Fig. 6, C and D). In
addition, the P1 phosphate interacts
directly as well as via a water bridge
with the side chain of Arg-97 and
with the side chain and backbone of
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Ser-98, both of which were disordered in the absence of phosphate (Fig. 6, C and D).
A poly-dentate anion appears to be required to engage in the
observed interactions and elicit the structural transition. In
agreement with this notion, a similar disorder-order transition
was observed upon soaking with sulfate ions (not shown),
whereas mono-dentate anions did not evoke any such change.
For example, 250 mM NaCl were present in all crystallization
and soaking experiments, and we did not observe any conformational changes in the structure soaked with an additional 0.5
M sodium iodide (Table 1). We, therefore, refer to the loop
between Gly-96 and Pro-106 of element II as the “phosphate
loop” (P-loop).
Upon binding of the P1 phosphate, the P-loop closes off part
of the active site of mmuSecSelast (Fig. 6, A and B). It is likely
that active site closure accompanies catalysis and may serve,
e.g. to locally exclude bulk water. Therefore, the 3⬘-end of
tRNA[Ser]Sec most likely gains access to the PLP cofactor
from the side opposite the P-loop (arrow in Fig. 6B).
We observed a second phosphate binding site remote from
the active site (P2 in Fig. 6B). This phosphate location could
indicate a site of contact to the tRNA[Ser]Sec phosphodiester
backbone. However, in contrast to the P-loop and Arg-313 (see
below), residues contacting the P2 phosphate (Arg-199, His368) are not conserved in SecS orthologs (Fig. 2). It is possible
that the binding of the P2 phosphate is not functional and
restricted to mouse and a few other SecSs.
Phosphate Binding Is Mediated by Conserved and SecS-specific
Residues That Are Essential for Selenocysteine Synthesis—
The P-loop is a highly conserved element of eukaryotic and
archaeal SecS, which is lacking from related enzymes with a
different function (Fig. 2). In particular, Arg-97, Ser-98, and
Gln-105 from the P-loop as well as Arg-313 from element III,
which directly contact the P1 phosphate, are strictly conserved
among SecS enzymes but not beyond. These observations are
consistent with the idea that the P-loop carries out an essential
function that is specific for SecSs.
To directly probe the importance of residues contacting the
P1 phosphate, we generated mutant mmuSecS proteins in
which Gln-105 was changed to Glu (mmuSecSQ105E) or Arg313 was changed to Ser or Glu (mmuSecSR313S;
mmuSecSR313E). All mutants were expressed as soluble proteins in E. coli, migrated as tetramers in gel filtration, and exhibited a PLP complement comparable with that of the wild type
protein, as indicated by their absorption maxima at 334 nm
(ketimine form) and 418 nm (aldimine form; not shown). We
tested the mutants for their ability to convert PSer-tRNA[Ser]Sec to
Sec-tRNA[Ser]Sec. Strikingly, each of the point mutants severely
corrupted the activity of mmuSecS (Fig. 7A). Although the
mmuSecSQ105E and mmuSecSR313S mutants still exhibited

activities of about 50 and 30% of the wild type protein, respectively, the R313E exchange rendered mmuSecS virtually inactive (Fig. 7A). The more severe effect with the negatively
charged Glu compared with the neutral Ser in place of Arg-313
directly supports the functional relevance of phosphate binding
at this position. These results directly link the ability of
mmuSecS to bind a phosphate or a related group via induced fit
of the P-loop to its catalytic competence. Based on these observations, we suggest that the P1 phosphate mimics binding of a
substrate or of a functional portion of a substrate.
The P-loop Could Serve as a Binding Site for the PSer ␥-Phosphate and SeP—We scrutinized the possibility that the ␥-phosphate of PSer-tRNA[Ser]Sec could be bound by the P-loop. To
this end we modeled the structure of an external aldimine comprising PLP in a Schiff-base linkage to a PSer esterified at the
␣-carboxylate. For modeling, we superimposed the structure of
PSer-aminotransferase in complex with the substrate mimic
␣-methyl-L-glutamate (49) onto the mmuSecSelast-phosphate
structure. We replaced the ␣-methyl-L-glutamate moiety with a
␣-carboxy ester of PSer, retained all side chain conformations
as observed in the mmuSecSelast structure in complex with
phosphate, and allowed the PLP moiety to adopt a slightly more
inclined orientation (Fig. 6E). Even without adjustments of the
protein matrix, the ␥-phosphate of the PSer ester could be
accommodated approximately at the P1 phosphate position.
These results suggest that the P-loop could serve to bind the
␥-phosphate of PSer-tRNA[Ser]Sec.
The similarity of phosphate and SeP suggests that the P1
phosphate could also mimic binding of the co-substrate SeP to
the P-loop. Binding of the PSer moiety and SeP to the P-loop
could occur sequentially and is not mutually exclusive (see
“Discussion”). In contrast, we did not manage to fit a phosphate
from the backbone of tRNA[Ser]Sec without clashes in the position of the P1 phosphate at the P-loop, consistent with our
above suggestion that the tRNA[Ser]Sec 3⬘-end approaches the
active site distal to the P-loop (Fig. 6B).
SecS Discriminates against Free O-Phospho-L-serine—Free
PSer is produced, for example, as an intermediate in the biosynthesis of serine by transamination from 3-phosphohydroxypyruvate. Therefore, SecS should be safeguarded against using
free PSer as a substrate. We tested this notion by attempting to
dephosphorylate free PSer with mmuSecS. Indeed, the enzyme
proved to be completely unreactive with respect to the free
amino acid (Fig. 7B).
We inspected the active site of mmuSecSelast for possible filtering devices. Typically, PLP-dependent enzymes of the fold
type I deploy a positively charged Arg in the neighborhood of
the PLP to bind the negatively charged ␣-carboxylate of an
amino acid substrate. In the absence of a substrate, a sulfate or
phosphate group often binds at an equivalent position as the

FIGURE 5. The mmuSecSelast tetramer. A, left, overview of the mmuSecSelast homotetramer, comprising a dimer of dimers (222 symmetry). Protomers (Mol I–IV)
are shown in different colors. Distances between active sites (PLP phosphates) are indicated (magenta lines). Right, overview of the E. coli cystathionine
␥-synthase (ecoCGS) homotetramer (PDB code 1CS1 (55)) drawn to scale and in the same orientation as the mmuSecSelast tetramer. B, stereo ribbon plot of the
N-terminal tetramerization motif. Selected residues are shown as ball-and-stick representations and color-coded by atom type. Dashed lines indicate hydrogen
bonds and salt bridges. C, electrostatic surface potential of the tetramer (calculated with PLP omitted). Blue, positive charge; red, negative charge. Large
positively charged patches, in particular around the active site funnel, can be discerned. Lys-284-bound PLP moieties are shown in gold at the bottom of the
active sites funnels. D, iodide ions (purple spheres) located in the structure of mmuSecSelast soaked in 0.5 M sodium iodide. E, hypothetical model of tRNA[Ser]Sec
binding to mmuSecSelast. No local conformational adjustments or energy minimizations were conducted in either the protein or the tRNA to optimize the fit.
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␣-carboxylate (43). The ␣-carboxylate binding Arg originates
in cis from the ␤-sheet in domain 3. An equivalent Arg is also
strictly conserved in SecS orthologs (Arg-404; Fig. 4B). However, in mmuSecSelast, its side chain is turned away from the
PLP. Arg-404 interacts instead by a cation- interaction with
Phe227 (another residue strictly conserved only in the SecS
orthologs; Fig. 2). It is additionally fixed by hydrogen bonds to
the side chain of Asn-435 and the
backbone carbonyl of Met-423 and
by water-mediated hydrogen bonds
to the backbone carbonyl of Ala-228
and to side chains of His-425 and
Tyr-433 (Fig. 4B). The side chain of
Arg-404 is thereby stably tugged
away, since it does not change orientation in the presence of even 0.5
M phosphate (as seen in our phosphate-soaked structure), suggesting
that Arg-404 is not involved in binding of a ␣-carboxylate.
As pointed out above, mmuSecSelast harbors Glu-74 in trans
next to the PLP moiety (Fig. 4, A and
B). Interestingly, Glu-74 occupies
the same spatial position as the
equivalent of Arg-404 in other fold
type I enzymes (Fig. 4, B and C). This
observation and our model of an
external aldimine of mmuSecS with
a PSer ester (Fig. 6E) demonstrate
that Glu-74 would strongly disfavor
productive placement of a substrate
with a free (negatively charged) ␣carboxylate. In PSer-tRNA[Ser]Sec,
however, the ␣-carboxylate of PSer
is esterified to the 2⬘- or 3⬘-hydroxyl
group of the 3⬘-terminal adenosine
and does not carry a negative
charge. Therefore, we expect that
Glu-74 acts as a substrate filter by
repelling compounds with a negatively charged ␣-carboxylate.
The Inhibition Profile of SecS
Resembles That of ␤-Lyases—To
gain additional insight into the
reaction mechanism of SecS, we
tested whether the dephosphorylation activity of mmuSecS is inhibited by the mechanism-based
inhibitors PG and F3-Ala. PG preferentially inhibits PLP-dependent
enzymes such as cystathionine
␥-lyase, which mediate lyase reactions at the ␥-carbon (50). In contrast, F3-Ala preferentially inhibits
enzymes such as cystathionine
␤-lyase, which mediate replacement of a substituent at the ␤-car-
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bon (51). Strikingly, mmuSecS is unaffected by up to 25 mM
PG (more than 12,500-fold excess over mmuSecS active
sites; Fig. 7C). In contrast, partial enzyme inhibition was
detected in the presence of 5 mM F3-Ala and above (Fig. 7C).
These inhibition profiles are in agreement with SecS catalyzing a ␤-replacement reaction with a high specificity. Furthermore, the data suggest that the lytic half-reaction of SecS
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follows the cystathionine ␤-lyase scheme, strongly supporting aminoacrylyl-tRNA[Ser]Sec as an intermediate (28).
Although our data do not allow us to derive exact inhibition
constants, we note that compared with E. coli cystathionine
␤-lyase (51), the inhibition of mmuSecS by F3-Ala is weak. For
example, in a comparable setup, the halftime for inactivation of
E. coli cystathionine ␤-lyase by 1 mM F3-Ala was less than 2 min
(52), whereas mmuSecS is not measurably affected under these
conditions (Fig. 7C). This observation is consistent with the
suggested substrate discrimination by Glu-74, since F3-Ala
exhibits a free ␣-carboxylate and is, therefore, expected to be
discouraged from forming an external aldimine.

DISCUSSION
SecS Orthologs Constitute a Unique Subclass of Fold Type I
PLP-dependent Enzymes—We have presented structural and
functional analyses of a mammalian SecS demonstrating how
SecS orthologs are set aside from other PLP-dependent
enzymes. Although mmuSecSelast is composed of three
domains whose structural scaffolds exhibit high similarity to
the fold type I family of PLP-dependent enzymes (Fig. 3), distinguishing structural and functional characteristics are conferred by remodeled elements both within and outside of these
conserved scaffolds (labeled I–IV in Fig. 3). These novel elements clearly define SecS orthologs as a special subclass of the
family.
Of paramount importance for the function of SecS are two
motifs that are unique to and highly conserved in SecS
orthologs. First, a special N terminus (element I) serves as a
tetramerization device. It reinforces the interaction between
two close dimers by cross-strutting (Fig. 5, A and B). Neither
afuPSerCysS nor NifS relatives nor synC-DES exhibit a comparable element, and all of these enzymes form dimers. As further
detailed below, we suggest that tetramerization could be crucial
for proper PSer-tRNA[Ser]Sec positioning. Second, a long insertion between helices ␣2 and ␣4 of domain 1 (element II) is
involved in catalysis by SecS. Via a first loop, element II provides residues Glu-74 and Arg-75, which anchor the PLP cofactor in trans. It thereby positions the negatively charged Glu-74
ideally to act as a substrate filter. Via a second loop it dispatches
the P-loop to the trans active site, which mediates binding of
SecS-specific substrates.
Evidently, the evolution of the unique N terminus and of the
long domain 1 insertion went hand in hand. Placing the N terminus at the outside of the protein, where it can engage in
tetramer formation, liberated a binding site between domains 1

and 3 as seen, e.g. in afuPSerCysS, NifS relatives, and synC-DES
proteins (Fig. 3). The first loop of the domain 1 insertion
evolved to take advantage of the liberated binding site between
domains 1 and 3 in trans. It thereby became ideally positioned
to contribute residues to the trans active site (Fig. 3A).
tRNA Selection Strategy of SecS—Our results highlight a
number of features that enable SecS to specifically recognize its
substrates. The highly positively charged surface of mmuSecSelast is apparently designed to interact at multiple sites with
the phosphodiester backbone of tRNA[Ser]Sec. This expected
mode of interaction is supported by our observations of numerous anion (iodide) binding sites (Fig. 5D), binding of a chloride
ion in untreated crystals (not shown), and binding of the P2
phosphate ion distal to the active sites in phosphate-soaked
crystals (Fig. 6B). tRNA[Ser]Sec exhibits a number of unique
structural characteristics compared with canonical tRNAs,
such as an elongated (9 ⫹ 4 base pairs) helical stack between the
acceptor stem and the T⌿C stem and an unusually long variable arm (8, 53). Multiple latching points on the surface of SecS
would allow the enzyme to recognize these global structural
features and discriminate against other tRNAs, which are in
vast excess in the cell. Thus, the tRNA selection strategy of SecS
may resemble that of bacterial SelA, which very inefficiently
converts Ser-tRNA[Ser]Sec mutants with a shortened, canonical
acceptor stem (54).
The mmuSecSelast active site environments are built up
entirely by residues originating from the two protomers of a
close dimer. Why then does mmuSecS form tetramers? One
possibility is that the tetramer provides an effective binding
platform for the large tRNA[Ser]Sec molecule. Although we have
no direct evidence for the mode of PSer-tRNA[Ser]Sec binding to
mmuSecS, portions of tRNA[Ser]Sec could extend beyond the
borders of the molecule to whose active site its 3⬘-end is
bound. To illustrate the relative sizes of the molecules and
how the SecS tetramer could serve as a binding platform for
tRNA[Ser]Sec, we generated a hypothetical docking model (Fig.
5E). A model of tRNA[Ser]Sec (as derived in Hubert et al. (53))
was positioned on the mmuSecSelast tetramer with the 3⬘-end
approaching the active site of one monomer distal to the
P-loop, leaving the P-loop available for accommodation of the
PSer moiety. The body of tRNA[Ser]Sec was then adjusted by
rotation about the 3⬘-terminal nucleotide to avoid clashes with
the protein. Significantly, the unique mode of tetramerization
provides the mmuSecS tetramer with a unique, elongated shape
(shown by the characteristic distances between the active sites;

FIGURE 6. Phosphate-induced conformational changes. A, native mmuSecSelast close dimer with one molecule shown as a light gray ribbon and the other as
a blue surface; the other protomers of the tetramer are shown as gray ribbons fading out. Residues 98 –104 (dashed line) of the P-loop (green) are completely
disordered. A Lys-284-bound PLP is shown in gold ball-and-stick representation. The view is the same as in Fig. 3A. B, upon binding of the P1 phosphate, the
previously disordered region of the P-loop becomes completely ordered and closes part of the active site like a lid (green surface). Bound phosphates are shown
as space-filling models (red, oxygen; pink, phosphorus). The P2 phosphate may indicate a distal site of attachment of a portion of the tRNA[Ser]Sec backbone. The
arrow indicates the likely access path of the tRNA[Ser]Sec 3⬘-end. C, stereo ribbon plot of the active site formed around the Lys-284-bound PLP of a reference
molecule (light gray backbone) with participation by the second protomer of the close dimer (steel blue backbone). The partially disordered (dashed line) flexible
P-loop of the second molecule is shown in green. The Lys-284-bound PLP and selected residues are shown as ball-and-stick representations and are color-coded
by atom type as before. Note that the side chains of Gln-105 and Arg-313 are turned away from the Lys-284-PLP moiety. The view is rotated 30° around the
vertical axis compared with the views in panels A and B. D, stereo ribbon plot of the same active site region after binding of the P1 phosphate. Gln-105 and
Arg-313 change their positions and orientations drastically to engage in hydrogen bonds viz. salt bridges to the phosphate oxygens. In addition, residues
Arg-97 and Ser-98 of the P-loop engage in phosphate binding, leading to a complete ordering of the P-loop. Orientation and color-coding are as in panel C.
Dashed lines indicate salt bridges and hydrogen bonds. E, model for binding of PSer esterified at the ␣-carboxyl (cyan sphere). Without major adjustments of the
protein matrix, the ␥-phosphate can be cradled in the P-loop similar to the free phosphate in D. Note that Glu-74 closely approaches the ␣-carboxy ester.
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FIGURE 7. Functional analysis of mmuSecS. A, mutational analysis of mmuSecS.
Conversion of [3H]PSer-tRNA[Ser]Sec to [3H]Sec-tRNA[Ser]Sec by mmuSecS (red),
mmuSecSQ105E (blue), mmuSecSR313S (dark green), and mmuSecSR313E (light
green). Trx (black) served as a negative control. B, dephosphorylation activity of
mmuSecS. Dephosphorylation of [32P]PSer-tRNA[Ser]Sec (lanes 1– 4) and [32P]PSer
(lanes 5–9) in the presence of varying amounts of mmuSecS is shown. Trx was
used as a negative control (lanes 1 and 5), and alkaline phosphatase (AP) was used
as a positive control for the generation of free [32P]Pi (lane 9). Details are given
under “Experimental Procedures.” C, inhibition studies of mmuSecS. [32P]PSertRNA[Ser]Sec dephosphorylation with mmuSecS (lane 1) in the presence of the
mechanism-based inhibitors PG (lanes 2–5) and F3-Ala (lanes 6 –9). Trx (lane 10)
served as a negative control. Details of reactions and monitoring conditions are
given under “Experimental Procedures.”

Fig. 5A). Other arrangements, such as the stubbier form of
E. coli cystathionine ␥-synthase (Fig. 5A) (55), generate other
relative dispositions of active sites. Thus, SecS may have
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evolved as a distinctly shaped tetramer to support efficient
PSer-tRNA[Ser]Sec binding by one dimer to position its 3⬘-end
appropriately in an active site of a neighboring dimer. A similar
principle may underlie the decameric organization of bacterial
SelA. Further experiments are required to test these ideas.
Mechanisms for Substrate Binding and Differentiation in the
Active Site—Our structural analyses have shown that the long,
conserved domain 1 insertion (element II) of mmuSecS does
not merely serve to support PLP anchoring in trans. Part of this
insertion, which we refer to as the P-loop, can undergo disorder-order transitions coupled to binding of poly-dentate ions
such as phosphate or sulfate. We interpret this observation as
direct evidence for the mode of substrate binding by mmuSecS.
Our molecular modeling suggests that the P1 phosphate could
resemble the binding of the ␥-phosphate of the PSer moiety of
PSer-tRNA[Ser]Sec (Fig. 6E). Evidently, SeP could also bind to
the P-loop in a similar fashion as the P1 phosphate. In contrast,
we could not position the tRNA[Ser]Sec phosphodiester backbone in the same way at the P-loop. In any case, the P-loop in
combination with Arg-313 (from element III) obviously binds
and positions phosphate portions of substrates by an induced fit
mechanism. This notion is perfectly borne out by our mutational analyses, which showed that the phosphate-coordinating
residues are crucial for mmuSecS activity (Fig. 7A).
In addition, we suggest that SecS has exploited the domain 1
insertion to install a filtering mechanism that allows it to
exclude free PSer and other free amino acids from its active site.
Glu-74, positioned strategically next to the trans PLP (Fig. 4, A
and B), adopts a similar spatial position as the side chain of an
Arg originating from the domain 3 ␤-sheet in related enzymes,
which typically serves as an ␣-carboxylate recognition device
(Fig. 4C). In SecS, an equivalent Arg is present, but it is turned
away via interactions with other conserved residues (Fig. 4B),
e.g. to engage in alternative interactions with the tRNA[Ser]Sec
portion. We suspect that Glu-74 repels negatively charged carboxyl groups of free amino acids. Neutral ester moieties as in
PSer-tRNA[Ser]Sec are presumably allowed to productively
approach the PLP internal aldimine. Our finding that SecS does
not convert free PSer supports the role of Glu-74 as a substrate
discriminator. Similar to the P-loop, the elements constituting
the putative substrate filter are highly conserved among SecS
orthologs but not beyond. Thus, SecS has acquired specialized
functional modules for substrate binding and differentiation.
␥-Phosphate binding at the P-loop provides a facile explanation for the observation that SecS binds PSer-tRNA[Ser]Sec preferentially over non-aminoacylated tRNA[Ser]Sec (28). However,
presently we can only speculate why Ser-tRNA[Ser]Sec is bound
with least efficiency (28). One clue is provided by the observations that the P-loop tends to bind substrate mimics such as
phosphate or sulfate and that PSer-tRNA[Ser]Sec, but not SertRNA[Ser]Sec, can compete efficiently with these molecules. The
unloaded 3⬘-end of tRNA[Ser]Sec may fit next to the contracted
P-loop without having to compete for binding at that place.
Another possibility is that ␥-phosphate binding at the P-loop
leads to proper accommodation of the PSer moiety and of the
tRNA[Ser]Sec 3⬘-end in the active site, whereas Ser at the 3⬘-end
may engage in alternative interactions, which could be mutually
exclusive with proper fitting of tRNA[Ser]Sec. Clarification of
VOLUME 283 • NUMBER 9 • FEBRUARY 29, 2008
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FIGURE 8. Proposed catalytic mechanism. Elements are color-coded: gold, PLP and the PLP-bound Lys-284; brown, liberated Lys-284; green, residues of the
P-loop; blue, Arg-313; black, PSer-tRNA[Ser]Sec; red, SeP). R in II–VI represents tRNA[Ser]Sec. I, formation of the Michaelis complex, most likely involving binding of
the ␥-phosphate of PSer-tRNA[Ser]Sec to the P-loop/Arg-313. In further steps, this binding site is symbolized by a green arch. II, abstraction of the ␣-proton from
the internal aldimine by Lys-284. III, phosphate elimination and generation of aminoacrylyl-tRNA[Ser]Sec; the evolving negative charge on the phosphate group
is compensated by protonation via Lys-284. IV, SeP replaces phosphate at the P-loop/Arg-313 binding site. We suggest that attack of the aminoacrylyltRNA[Ser]Sec intermediate by SeP involves concomitant attack by a water molecule on SeP. A general base (B) is proposed to activate this water molecule.
Activation could be supported by a circular protonic shift involving Lys-284. V and VI, reverse transaldimination, regenerating the active site and release of the
product, Sec-tRNA[Ser]Sec. Further details are given under “Discussion.”.

these issues may require elucidation of a SecS-tRNA[Ser]Sec
complex structure.
Structure-based Reaction Mechanism—NifS-like enzymes
mobilize sulfur for iron-sulfur cluster biosynthesis via a protein-bound persulfide using a conserved cysteine that lies in a
long loop of domain 3 (element IV in Fig. 3, A and B) (43).
synC-DES employs a related strategy by generating an external
cysteine persulfide via cystine C-S cleavage, which remains
non-covalently fixed at the active site (47). Furthermore, it has
been discussed that PSerCysS could also employ a persulfide
mechanism (41). Because NifS can support selenide delivery
(56), SecS could function in an analogous fashion by using a
perselenide intermediate. However, although SecS exhibits a
domain 3 loop analogous to the persulfide loop of NifS
enzymes, no cysteine that could serve as attachment site for
FEBRUARY 29, 2008 • VOLUME 283 • NUMBER 9

selenium is present in that loop. The only cysteine that is conserved in eukaryotes in the active site cavity is Cys-226 (Fig. 2).
However, its sulfur atom is still more than 7 Å away from any
atom of the PLP and remote from the modeled substrate. In
addition, this residue is not conserved in archaeal SecS (Fig. 2).
Furthermore, in light of the observation that SeP delivered by
selenophosphate synthetase 2 is the active selenium donor of
SecS (24, 28), internal or external perselenide production (via
SeP) appears to be an off-pathway reaction. Under these circumstances it is unlikely that SecS functions via an intermediate perselenide moiety.
Instead, a mechanism that is consistent with all our findings
evokes direct selenide delivery by SeP (Fig. 8). As suggested by
the inhibition results, we based the first part of the scheme on
the E. coli cystathionine ␤-lyase mechanism (51). In our workJOURNAL OF BIOLOGICAL CHEMISTRY
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ing model the process is initiated by PSer-tRNA[Ser]Sec binding
and positioning of the ␥-phosphate at the P-loop (Fig. 8, I).
Lys-284 is expected to be deprotonated after liberation upon
external aldimine formation, constituting a strong base suitable
for abstracting the ␣-hydrogen from the substrate (Fig. 8, II).
Phosphate release would generate aminoacrylyl-tRNA[Ser]Sec as
an intermediate (Fig. 8, III and IV). Next, the liberated phosphate is exchanged for SeP at the P-loop (Fig. 8, IV), which
would then be ideally situated to donate Se2⫺ to the ␤-carbon of
the aminoacrylate moiety (Fig. 8, IV and V). We suggest that
attack of the aminoacrylyl-tRNA[Ser]Sec intermediate by SeP
involves concomitant attack by a water molecule on SeP, again
giving rise to a phosphate leaving group (Fig. 8, IV and V). A
general base is proposed to activate this water molecule via a
circular protonic shift involving Lys-284 (Fig. 8, IV). Subsequent reverse transaldimination (Fig. 8, V and VI) liberates the
product, Sec-tRNA[Ser]Sec, and regenerates the internal
aldimine.
Details of the above model are still in the dark. For example,
we presently envision sequential binding and conversion of the
substrates coupled to repeated contraction and relaxation of
the P-loop since our phosphate-soaking experiments only
revealed a single phosphate binding site. However, we cannot
rigorously exclude the possibility for a separate binding pocket
for SeP at the present time. Furthermore, the identity of the
water-activating general base is unknown at the time. This
function could involve residues from the P-loop/Arg-313 (for
example, note the water bound to Arg-97 and phosphate in Fig.
6D). In archaeal SecS, the proposed water activation could be
provided by the histidine residue stacking on the PLP. It is also
conceivable that Lys-284 directly activates the water molecule
without an intervening general base. Evoking a similar scenario,
it has been shown that the PLP-binding lysine in E. coli cystathionine ␥-synthase can reach to distal regions of the substrate
(55). Work is in progress to further corroborate and refine this
mechanism. To this end, our high resolution crystal structures
of mmuSecSelast provide excellent leads for further rational sitedirected mutagenesis.
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54. Baron, C., and Böck, A. (1991) J. Biol. Chem. 266, 20375–20379
55. Clausen, T., Huber, R., Prade, L., Wahl, M. C., and Messerschmidt, A.
(1998) EMBO J. 17, 6827– 6838
56. Lacourciere, G. M., and Stadtman, T. C. (1998) J. Biol. Chem. 273,
30921–30926
57. Notredame, C., Higgins, D. G., and Heringa, J. (2000) J. Mol. Biol. 302,
205–217
58. Davis, I. W., Murray, L. W., Richardson, J. S., and Richardson, D. C. (2004)
Nucleic Acids Res. 32, 615– 619
59. Krissinel, E., and Henrick, K. (2004) Acta Crystallogr. D Biol. Crystallogr.
60, 2256 –2268

[ SUPPLEMENT Figure S1 follows. ]
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SUPPLEMENT
Figure S1: Electron density. Experimental SIRAS electron density (blue mesh) at 2.0 Å resolution after
solvent flattening contoured at the 1σ level. A. Density covering one molecule of a tetramer. The other three
protomers are indicated as light gray ribbons. B. SIRAS density of a α-helical element with the final model
indicated as yellow ball-and-sticks.
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